We are live on
!
Find out more
RhumbLine Advisers Portfolio holdings
AUM
$117B
1-Year Est. Return
29.66%
This Fund
S&P 500
This Quarter
Est. Return
+0.71%
1 Year Est. Return
+29.66%
3 Year Est. Return
+101.47%
5 Year Est. Return
+137.35%
10 Year Est. Return
+530.91%
AUM
$33.3B
AUM Growth
-$783M
(-2.3%)
Cap. Flow
-$715M
Cap. Flow
% of AUM
-2.15%
Top 10 Holdings %
Top 10 Hldgs %
15.9%
Holding
3,039
New
28
Increased
1,056
Reduced
1,268
Closed
57
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
AGN
Allergan plc
AGN
|
+$29M |
| 2 |
DISCK
Discovery, Inc. Series C Common Stock
DISCK
|
+$14M |
| 3 |
Microsoft
MSFT
|
+$10.8M |
| 4 |
Meta Platforms (Facebook)
META
|
+$10.5M |
| 5 |
iShares Russell 1000 Growth ETF
IWF
|
+$6.72M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$34.4M |
| 2 |
FRX
FOREST LABORATORIES INC
FRX
|
+$32.2M |
| 3 |
ExxonMobil
XOM
|
+$23.9M |
| 4 |
Warner Bros
WBD
|
+$15.4M |
| 5 |
RTX Corp
RTX
|
+$13.7M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 14.81% |
| 2 | Financials | 14.8% |
| 3 | Healthcare | 13.73% |
| 4 | Industrials | 10.72% |
| 5 | Energy | 8.73% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
226
W.W. Grainger
GWW
$64B
| $26M | 0.08% |
103,271
-19,713
| -16% | -$4.84M |
|
|
CERN
227
DELISTED
Cerner Corp
CERN
| $25.9M | 0.08% |
435,053
-6,182
| -1% | -$347K |
|
228
Moody's
MCO
$83.5B
| $25.8M | 0.08% |
272,981
-104,411
| -28% | -$9.57M |
|
229
Prologis
PLD
$136B
| $25.5M | 0.08% |
676,069
-14,663
| -2% | -$594K |
|
230
Parker-Hannifin
PH
$121B
| $25.4M | 0.08% |
222,925
-4,579
| -2% | -$540K |
|
|
STI
231
DELISTED
SunTrust Banks, Inc.
STI
| $25.4M | 0.08% |
667,309
-18,083
| -3% | -$698K |
|
232
Invesco
IVZ
$13B
| $25M | 0.08% |
634,092
+43,444
| +7% | +$1.71M |
|
233
Dollar General
DG
$28.1B
| $24.8M | 0.07% |
406,594
-4,277
| -1% | -$256K |
|
|
GMCR
234
DELISTED
KEURIG GREEN MTN INC
GMCR
| $24.8M | 0.07% |
190,513
-2,016
| -1% | -$252K |
|
235
Las Vegas Sands
LVS
$32.3B
| $24.7M | 0.07% |
397,749
+962
| +0.2% | +$66.1K |
|
236
AutoZone
AZO
$49.1B
| $24.6M | 0.07% |
48,313
-1,534
| -3% | -$808K |
|
237
Alcoa
AA
$11.9B
| $24.6M | 0.07% |
636,460
-9,117
| -1% | -$357K |
|
238
Healthpeak Properties
DOC
$15.2B
| $24.6M | 0.07% |
679,173
-20,273
| -3% | -$769K |
|
239
Vornado Realty Trust
VNO
$7.55B
| $24.6M | 0.07% |
335,846
-9,441
| -3% | -$728K |
|
|
STJ
240
DELISTED
St Jude Medical
STJ
| $24.5M | 0.07% |
406,669
-10,717
| -3% | -$700K |
|
241
Intuitive Surgical
ISRG
$126B
| $24.4M | 0.07% |
474,975
-27,648
| -6% | -$1.37M |
|
242
Public Service Enterprise Group
PEG
$38.6B
| $24.4M | 0.07% |
654,376
-102,923
| -14% | -$3.8M |
|
243
Agilent Technologies
A
$39.2B
| $24.3M | 0.07% |
597,094
-15,533
| -3% | -$634K |
|
244
Amphenol
APH
$197B
| $24.3M | 0.07% |
1,949,576
-121,912
| -6% | -$1.53M |
|
245
AvalonBay Communities
AVB
$26.8B
| $24.2M | 0.07% |
171,593
+1,675
| +1% | +$248K |
|
246
Paychex
PAYX
$41.4B
| $24M | 0.07% |
542,454
-32,677
| -6% | -$1.37M |
|
247
Boston Properties
BXP
$11.4B
| $23.9M | 0.07% |
206,895
-7,873
| -4% | -$942K |
|
|
FISV
248
Fiserv Inc
FISV
$28.8B
| $23.8M | 0.07% |
735,316
-24,294
| -3% | -$768K |
|
249
Rockwell Automation
ROK
$52.4B
| $23.8M | 0.07% |
216,248
-448
| -0.2% | -$52.6K |
|
250
Weyerhaeuser
WY
$16.9B
| $23.4M | 0.07% |
735,871
-72,326
| -9% | -$2.37M |
|
Similar funds
VAM
RhumbLine Advisers's Q3 2014 Portfolio in Review
As of Q3 2014, RhumbLine Advisers held 3,039 positions worth $33.3B, down 2.3% from $34.1B the previous quarter. Its ten largest holdings account for 16% of the portfolio.
Trading was light in Q3 2014: portfolio turnover was 2.8%. RhumbLine Advisers opened 28 new positions and exited 57, leaving the 3,039-position portfolio largely intact.
By sector, the portfolio is most concentrated in Technology at 15% of assets, up from 14% a quarter earlier, followed by Financials and Healthcare.
- RhumbLine Advisers's largest Q3 2014 buy was Discovery, Inc. Series C Common Stock: 346,925 shares worth $12.9M.
- RhumbLine Advisers added most to Allergan plc in Q3 2014, an estimated $29M increase.
- RhumbLine Advisers's biggest Q3 2014 reduction was Apple, cutting an estimated $34.4M.
- RhumbLine Advisers fully exited FOREST LABORATORIES INC in Q3 2014, selling an estimated $32.2M.
- RhumbLine Advisers's ten largest holdings make up 16% of its $33.3B portfolio in Q3 2014.
- RhumbLine Advisers opened 28 new positions and closed 57 in Q3 2014.
- RhumbLine Advisers's portfolio value fell 2.3% quarter-over-quarter to $33.3B.
Based on RhumbLine Advisers's 13F filing for Q3 2014, filed 12 Nov 2014.